May 2021 - Incacare

Management of invasive candidiasis and candidaemia in critically ill adults

Objective The global burden of invasive fungal disease is increasing. Candida albicans remains the leading cause of fungal bloodstream infections, although non-albicans candidal infections are emerging. Areas of controversy regarding…

0 Comments

May 25, 2021

Journal Scan

Increased susceptibility to intensive care unit acquired pneumonia

Background The aim of this study is to determine whether severe COVID-19 patients harbour a higher risk of ICU-acquired pneumonia. Methods This retrospective multicentre cohort study comprised all consecutive patients…

0 Comments

May 11, 2021

Drug Updates

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections

Abstract Triazole resistant A. fumigatus has been documented in many parts of the world. In the Netherlands, incidence is now above 10% and results in the need for long-term parenteral…

0 Comments

May 4, 2021